We are excited to welcome Ben Maurey to Reglagene as our commercial-focused advisor on our Advisory Board. Ben comes to Reglagene after 8 years in the oncology space with a wide variety of roles and responsibilities. He started his career off in strategic consulting and eventually ran the Market Strategy Team at Vaniam Group, with his team focusing on early asset and market access strategy. Most recently, Ben ran market insights for early stage assets at Seagen and continued with the company after they were acquired by Pfizer. In addition to his commercial consulting and industry experience Ben has assisted with clinical/medical affairs strategy and was a Venture Partner at The Cancer Fund.

Last week, Teri Suzuki, Lilian Patrón, and Michael Abrahamson participated in the 16th Annual BIO5/BIOSA Student Industry Networking Event.

Michael Abrahamson, an alumnus of the R. Ken Coit School of Pharmacy, presented his insights on personal growth and the value of making diverse connections after pharmacy school.

Find out how we were able to enter preclinical development at 10% of the cost in the interview.

Reglagene is honored to announce our partnership with Tech Coast Angels.

We have an incredible opportunity to join our team for a 3 month internship.

We are thrilled to unveil our all-new website, marking an important milestone for Reglagene!

Help us become the 2023 Inno Madness Champion!